Attorney General Jackley Settles with Three Additional Generic Drug Companies on Price Fixing

FOR IMMEDIATE RELEASE: Thursday, Oct. 8, 2026

Contact: Tony Mangan, Communications Director, 605-773-6878 

PIERRE, S.D. – South Dakota Attorney General Marty Jackley has joined 45 states and territories in seeking court approval of three settlements with Ascend Laboratories, Citron Pharma and Mayne Pharma to resolve allegations that the generic drug manufacturers engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade with regard to numerous generic prescription drugs.  South Dakota will receive funds from two of the three companies involved in the settlement.

“This is another step in the effort of Attorneys General to hold generic drug companies accountable for financially harming their customers and ending price fixing prices,” said Attorney General Jackley. “As part of these settlements, money is being allocated to customers who have been impacted.”

Ascend will pay $400,000 to the states. Mayne will pay $650,000. Citron’s settlement only includes non-monetary terms as it has ceased business operations. As part of the settlement, the companies each agreed to injunctive terms including a series of internal reforms to ensure fair competition and compliance with antitrust laws.  

Mayne will pay South Dakota $462.73 with another $223.95 going to Medicaid. Ascend will pay South Dakota $284.76 and Medicaid will receive $137.81. The state’s share of the settlements will go to the Attorney General’s Antitrust Fund, which is administered by the courts. Additionally, monies are being allocated to the customers that have been adversely impacted.

These latest settlements come as the States prepare for the first trial to be held in Hartford, Connecticut in February 2027.  The States previously reached settlements with Sandoz, Glenmark, Lannett, Bausch, Apotex and Heritage, and Heritage’s parent company, Emcure, totaling $496.5 million.   

If you purchased a generic prescription drug between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (Toll-Free), email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com. You can submit a claim for compensation here.    

States and territories joining the settlements include: Alaska, Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Florida, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming. 

                                                                    -30-